Arvind Sood | Vice President of Investor Relations |
Bob Bradway | Chairman and Chief Executive Officer |
Murdo Gordon | Executive Vice President, Global Commercial Operations |
Dave Reese | Executive Vice President, Research and Development |
Peter Griffith | Chief Financial Officer |
Mohit Bansal | Wells Fargo |
Michael Yee | Jefferies |
Salveen Richter | Goldman Sachs |
Jay Olson | Oppenheimer |
Chris Raymond | Piper Sandler |
Umer Raffat | Evercore ISI |
Yaron Werber | TD Cowen |
Gregory Renza | RBC Capital Markets |
Evan Seigerman | BMO |
Colin Bristow | UBS |
Dane Leone | Raymond James |
David Risinger | Leerink Partners |
Robin Karnauskas | Truist Securities |
My name is Julianne and I’ll be your conference facilitator today for Amgen’s Second Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speakers prepared remarks. In order to ensure that everyone has a chance to participate, we would like to request that you limit yourself to asking one question during the Q&A session. [Operator Instructions]